A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and Efficacy of Faropenem in
community-acquired pneumonia (CAP) subjects，and explore its therapeutic dose.
Phase:
Phase 2
Details
Lead Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd